Aeterna Zentaris Inc (AEZS) - Financial and Strategic SWOT Analysis Review

Aeterna Zentaris Inc (AEZS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Aeterna Zentaris Inc (Aeterna Zentaris) is a specialty biopharmaceutical company that focuses on the development and commercialization of novel pharmaceutical therapies for the treatment of unmet medical needs. The companys lead product, Macrilen (macimorelin), a ghrelin receptor agonist and orally active small molecule is used for the treatment of patients with adult growth hormone deficiency (AGHD). The company has operations in the US, Canada, Germany and has license agreements for its products in Ireland, China, British Virgin Islands, Denmark and other countries. Aeterna Zentaris is headquartered in Summerville, South Carolina, the US.

Aeterna Zentaris Inc Key Recent Developments

May 06,2020: Aeterna Zentaris reports first quarter 2020 financial and operating results
Mar 30,2020: Aeterna Zentaris reports fourth quarter and full-year 2019 financial and operating results and provides business update
Dec 16,2019: Aeterna Zentaris announces 2020 director changes
Nov 07,2019: Aeterna Zentaris reports third quarter 2019 financial and operating results
Oct 04,2019: Aeterna Zentaris announces appointment of New President and Chief Executive Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company




Section 1 - About the Company
Aeterna Zentaris Inc - Key Facts
Aeterna Zentaris Inc - Key Employees
Aeterna Zentaris Inc - Key Employee Biographies
Aeterna Zentaris Inc - Major Products and Services
Aeterna Zentaris Inc - History
Aeterna Zentaris Inc - Company Statement
Aeterna Zentaris Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Aeterna Zentaris Inc - Business Description
Product Category: License Fee
Performance
Product Category: Product Sales
Performance
Product Category: Royalty Income
Performance
Product Category: Sales commission
Performance
Product Category: Supply Chain
Performance
Geographical Segment: British Virgin Islands
Performance
Geographical Segment: China
Performance
Geographical Segment: Denmark
Performance
Geographical Segment: Ireland
Performance
Geographical Segment: Others
Performance
Geographical Segment: United States
Performance
R&D Overview
Aeterna Zentaris Inc - Corporate Strategy
Aeterna Zentaris Inc - SWOT Analysis
SWOT Analysis - Overview
Aeterna Zentaris Inc - Strengths
Aeterna Zentaris Inc - Weaknesses
Aeterna Zentaris Inc - Opportunities
Aeterna Zentaris Inc - Threats
Aeterna Zentaris Inc - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
Aeterna Zentaris Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Aeterna Zentaris Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Aeterna Zentaris Inc, Recent Deals Summary
Section 5 Companys Recent Developments
May 06, 2020: Aeterna Zentaris reports first quarter 2020 financial and operating results
Mar 30, 2020: Aeterna Zentaris reports fourth quarter and full-year 2019 financial and operating results and provides business update
Dec 16, 2019: Aeterna Zentaris announces 2020 director changes
Nov 07, 2019: Aeterna Zentaris reports third quarter 2019 financial and operating results
Oct 04, 2019: Aeterna Zentaris announces appointment of New President and Chief Executive Officer
Aug 20, 2019: Aeterna Zentaris announces director change
Aug 13, 2019: Aeterna Zentaris reports second quarter 2019 financial and operating results
Jun 06, 2019: Aeterna Zentaris provides corporate update
May 07, 2019: Aeterna Zentaris announces first quarter 2019 financial results
Mar 26, 2019: Aeterna Zentaris announces fourth quarter and full-year 2018 financial and operating results
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables


Aeterna Zentaris Inc, Key Facts
Aeterna Zentaris Inc, Key Employees
Aeterna Zentaris Inc, Key Employee Biographies
Aeterna Zentaris Inc, Major Products and Services
Aeterna Zentaris Inc, History
Aeterna Zentaris Inc, Subsidiaries
Aeterna Zentaris Inc, Key Competitors
Aeterna Zentaris Inc, Ratios based on current share price
Aeterna Zentaris Inc, Annual Ratios
Aeterna Zentaris Inc, Annual Ratios (Cont...1)
Aeterna Zentaris Inc, Annual Ratios (Cont...2)
Aeterna Zentaris Inc, Interim Ratios
Aeterna Zentaris Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Aeterna Zentaris Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Aeterna Zentaris Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures


Aeterna Zentaris Inc, Performance Chart (2015 - 2019)
Aeterna Zentaris Inc, Ratio Charts
Aeterna Zentaris Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Aeterna Zentaris Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

Aeterna Zentaris Inc (AEZS) - Financial and Strategic SWOT Analysis Review

Aeterna Zentaris Inc (AEZS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

AEterna Zentaris Inc Strategic Analysis Review- AEterna Zentaris Inc SWOT, Outlook, Operations and Financial Profile

AEterna Zentaris Inc Company Profile provides strategic analysis of AEterna Zentaris Inc Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth

USD 200 View Report

AEterna Zentaris Inc Strategic Analysis Review- AEterna Zentaris Inc SWOT, Outlook, Operations and Financial Profile

AEterna Zentaris Inc Company Profile provides strategic analysis of AEterna Zentaris Inc Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth

USD 200 View Report

Aeterna Zentaris Inc (AEZS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Aeterna Zentaris Inc (Aeterna Zentaris) is a specialty biopharmaceutical company which develops and commercializes therapies for the treatment of cancer, endocrine disorders and infectious diseases. The pipeline products of the

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available